Association of plasma urokinase-type plasminogen activator and its receptor with clinical outcome in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder

By Shariat S.F.   Monoski M.A.   Andrews B.   Wheeler T.M.   Lerner S.P.   Slawin K.M.  

Urology, Vol. 61, Iss. 5, 2003-05 ,pp. : 1053-1058

Elsevier

Access to resources Recommend Favorite

Significance of Coexpression of Urokinase-type Plasminogen Activator, and Matrix Metalloproteinase 3 (Stromelysin) and 9 (Gelatinase B) in Colorectal Carcinoma

By Inuzuka K.   Ogata Y.   Nagase H.   Shirouzu K.  

Journal of Surgical Research, Vol. 93, Iss. 2, 2000-10 ,pp. : 211-218

Academic Press

Access to resources Recommend Favorite

IL-8-Stimulated Expression of Urokinase-Type Plasminogen Activator in Human Skin and Human Epidermal Cells

By Han Y-P.   Hughes M.W.   Nien Y-D.   Garner W.L.  

Journal of Surgical Research, Vol. 106, Iss. 2, 2002-08 ,pp. : 328-334

Academic Press

Access to resources Recommend Favorite

Prognostic significance of angiogenesis in superficial bladder cancer

By Stavropoulos N.   Bouropoulos C.   Ioachim I.   Michael M.   Hastazeris K.   Tsimaris I.   Kalogeras D.   Liamis Z.   Stefanaki S.   Agnantis N.  

International Urology and Nephrology, Vol. 36, Iss. 2, 2004-06 ,pp. : 163-167

Springer Publishing Company

Access to resources Recommend Favorite

Increased levels of urokinase plasminogen activator receptor in prostate cancer cells derived from repeated metastasis

By Forbes Katie  

World Journal of Urology, Vol. 22, Iss. 1, 2004-04 ,pp. : 67-71

Springer Publishing Company

Access to resources Recommend Favorite